［1］ Branch DW, Gibson M, Silver RM. Clinical practice. Recurrent miscarriage［J］. N Engl J Med, 2010,363(18), 1740-1747 .

［2］ McNamee K, Dawood F, Farquharson RG. Thrombophilia and early pregnancy loss［J］. Best Pract Res Clin Obstet Gynaecol, 2012,26(1):91-102 . 

［3］ Bradley LA, Palomaki GE, Bienstock J, et al. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?Results from a targeted evidence-based review［J］. Genet Med, 2012,14(1):39-50 .

［4］ Brenner B. Hypercoagulability and recurrent miscarriages［J］. Clin Adv Hematol Oncol, 2010, 8(7):467-469 .

［5］ Bennett SA, Bagot CN, Arya R.Pregnancy loss and thrombophilia: the elusive link［J］. Br J Haematol, 2012, 157(5):529-542 .

［6］ Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review［J］. Br J Haematol, 2006,132(2):171-196 .

［7］ Lissalde-Lavigne G, Fabbro-Peray P, Cochery-Nouvellon E, et al. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control NOHA first' study［J］. J Thromb Haemost，2005, 3(10): 2178-2184 .

［8］ Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis［J］. Lancet, 2003, 361(9361): 901-908 . 

［9］ Finan RR, Tamim H, Ameen G. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population［J］. Am J Hematol,2002,71(4):300-305 .

［10］ Dawood F, Farquharson R, Quenby S, et al.Acquired activated protein C resistance may be a risk factor for recurrent fetal loss［J］. Fertil Steril, 2003,80(3), 649-650 .

［11］ Lindqvist PG, Svensson P, Dahlback B. Activated protein C resistance in the absence of factor V Leiden and pregnancy［J］. J Thromb Haemost, 2006, 4(2),361-366 .

［12］ Rai R, Shlebak A, Cohen H, et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage［J］. Hum Reprod, 2001,16(5), 961-965 .

［13］ Ren A, Wang J. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis［J］. Fertil Steril, 2006,86(6):1716-1722 . 

［14］ Greer IA. Antithrombotic Therapy for Recurrent Miscarriage? ［J］.N Engl J Med，2010, 362(17):1630-1631 .

［15］ Tersigni C, Marana R, Santamaria A, et al. In Vitro Evidences of Heparin's Effects on Embryo Implantation and Trophoblast Development［J］. Reprod Sci, 2012,19(5) 454-462 .

［16］ Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy［J］. Blood,2005,106(2):401-407 .